Nevro is a medical device company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS).
We explored beyond traditional SCS frequencies (40–60 Hz) in search of better therapeutic outcomes. Combining high frequency at 10 kHz with a unique waveform and a specific treatment algorithm resulted in HF10 therapy: a paresthesia-free treatment proven to provide more pain relief to more patients in more pain areas.1
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
The Senior Manager, Patient Access will focus on improving access to Nevro’s HF10 therapy for eligible patients. This individual will manage all aspects of the NevroCare database, including enhancement efforts and improved connectivity to other Nevro databases. The goal of these efforts is to provide actionable data that increases Nevro business and improves access to a superior therapy for patients. The Senior Manager will be responsible for analyzing and reporting on payer trends and individual patient progress for internal and external customers. The Senior Manager will also work closely with the NevroCare Patient Support Specialist team to provide direction, quality control, implement work processes and provide expertise regarding the management of prior authorization and claim appeal activities with customers.